Impact Biomedical (IBO) Change in Account Payables (2022 - 2026)
Impact Biomedical (IBO) posted Change in Account Payables of $27000.0 for Q1 2026, down 95.55% on a QoQ basis from $607000.0 in Q4 2025, and up 127.55% year-over-year from $11865.5 in Q1 2025.
Impact Biomedical (IBO) Change in Account Payables (2022 - 2026) Analysis & Trends
Impact Biomedical's Change in Account Payables history runs 5 years deep, the most recent figure standing at $27000.0 for Q1 2026.
- Quarterly Change in Account Payables rose 127.55% year-over-year to $27000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $595000.0 (up 182.07% YoY) and the FY2025 annual result came in at $470000.0, up 207.8% from the prior year.
- Change in Account Payables was $27000.0 for Q1 2026 at Impact Biomedical, down from $607000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $607000.0 in Q4 2025 and bottomed at -$605000.0 in Q4 2024.
- A 5-year average of $52266.7 and a median of $22000.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables soared 369.23% — and 2024, when it slumped 269.94%.
- Impact Biomedical's Change in Account Payables stood at $495000.0 in 2022, then dropped by 28.08% to $356000.0 in 2023, then slumped by 269.94% to -$605000.0 in 2024, then soared by 200.33% to $607000.0 in 2025, then slumped by 95.55% to $27000.0 in 2026.
- Business Quant data shows IBO's Change in Account Payables at $27000.0 in Q1 2026, $607000.0 in Q4 2025, and $22000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 607,000.00 |
| Dec 31, 2025 | 607,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | -61,000.00 |
| Jun 30, 2025 | -61,000.00 |
| Mar 31, 2025 | -98,000.00 |
| Mar 31, 2025 | -98,000.00 |
| Dec 31, 2024 | -605,000.00 |
| Dec 31, 2024 | -605,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Mar 31, 2024 | 191,000.00 |
| Mar 31, 2024 | 191,000.00 |
| Dec 31, 2023 | 356,000.00 |
| Dec 31, 2023 | 356,000.00 |